Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
4
×
cancer
life sciences
national
4
×
national blog main
national top stories
pfizer
4
×
raleigh-durham blog main
raleigh-durham top stories
roche
4
×
san francisco blog main
san francisco top stories
amgen
biotech ipos
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bridgebio
fda
glaxosmithkline
immunotherapy
investing
What
bio
cancer
roundup
advantages
alliance
annual
ash
bar
barcelona
blood
brings
bristol
broader
buy
calls
changing
clinical
color
company
conference
crispr
days
december's
detect
developing
drug
esmo
european
expect
files
firms
gamble
grail
growing
hours
intended
investors
ipo
join
kras
Language
unset
4
×
Current search:
pfizer
×
national
×
roche
×
" boston top stories "
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
